USD 23.15
(-1.53%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 961.52 Million USD | -10.95% |
2022 | 1.07 Billion USD | -3.39% |
2021 | 1.11 Billion USD | 19.18% |
2020 | 937.76 Million USD | -4.59% |
2019 | 982.9 Million USD | -5.57% |
2018 | 1.04 Billion USD | -2.47% |
2017 | 1.06 Billion USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 234.5 Million USD | -3.94% |
2024 Q2 | 233.47 Million USD | -0.44% |
2024 Q3 | 230.49 Million USD | -1.28% |
2023 Q4 | 244.13 Million USD | 0.55% |
2023 FY | 961.52 Million USD | -10.95% |
2023 Q3 | 242.8 Million USD | 2.02% |
2023 Q2 | 237.99 Million USD | 0.59% |
2023 Q1 | 236.59 Million USD | -1.86% |
2022 Q3 | 250.45 Million USD | -13.67% |
2022 Q2 | 290.12 Million USD | -2.66% |
2022 Q1 | 298.04 Million USD | -0.07% |
2022 FY | 1.07 Billion USD | -3.39% |
2022 Q4 | 241.08 Million USD | -3.74% |
2021 Q4 | 298.25 Million USD | 3.48% |
2021 Q3 | 288.21 Million USD | 4.32% |
2021 Q2 | 276.27 Million USD | 8.4% |
2021 Q1 | 254.86 Million USD | -72.82% |
2021 FY | 1.11 Billion USD | 19.18% |
2020 Q1 | 252.02 Million USD | 2.28% |
2020 Q4 | 937.76 Million USD | 319.55% |
2020 Q3 | 223.51 Million USD | 8.04% |
2020 Q2 | 206.88 Million USD | -17.91% |
2020 FY | 937.76 Million USD | -4.59% |
2019 Q3 | 245.82 Million USD | 0.2% |
2019 Q1 | 245.33 Million USD | 0.0% |
2019 FY | 982.9 Million USD | -5.57% |
2019 Q4 | 246.4 Million USD | 0.24% |
2019 Q2 | 245.33 Million USD | 0.0% |
2018 FY | 1.04 Billion USD | -2.47% |
2017 FY | 1.06 Billion USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
American Well Corporation | 259.04 Million USD | -271.177% |
Doximity, Inc. | 475.42 Million USD | -102.246% |
Evolent Health, Inc. | 1.96 Billion USD | 51.04% |
Phreesia, Inc. | 356.29 Million USD | -169.864% |
Teladoc Health, Inc. | 2.6 Billion USD | 63.053% |
Veeva Systems Inc. | 2.36 Billion USD | 59.321% |